Prehemolytic effects of hydrogen peroxide and t-butylhydroperoxide on selected red cell properties.
To provide further understanding of how oxidative damage affects red cell membrane function, the effects of low levels of two different types of oxidants on selected red cell properties have been studied. Hydrogen peroxide (H2O2), an example of a water soluble oxidant, and t-butylhydroperoxide (tBHP), a hydrophobic hydroperoxide, were compared with respect to their effects on membrane permeability, membrane mechanical properties and binding of autologous serum antibodies to the cell surface. Whereas H2O2 treatment resulted in a dose-dependent increase in membrane permeability to potassium that was evident after one hour of oxidant exposure, cells treated with tBHP at doses up to 5 mumol/ml cells showed no immediate change in cation permeability. H2O2 also caused a marked decrease in membrane deformability, whereas tBHP-treated cells showed minimal loss of deformability. However, tBHP treatment did result in a dose-dependent increase in the susceptibility of the membrane to fragmentation under high shear stress. With exclusion of treated samples that bound excess rabbit anti-spectrin antibody, indicating exposure of intracellular components, neither agent promoted the binding of autologous serum antibody in amounts comparable to that found in vivo on high density or some pathologic red cells. Taken together, the results suggest that tBHP and H2O2 cause damage to human red cells by distinct oxidative mechanisms which do not lead directly to substantive generation of binding sites for autologous serum antibodies.
Chen
M J
MJ
Center for Advanced Medical Technology, San Francisco State University, CA.
Sorette
M P
MP
Chiu
D T
DT
Clark
M R
MR
D002245:Carbon Dioxide / Q000494:pharmacology; D002463:Cell Membrane Permeability / Q000187:drug effects*; D004907:Erythrocyte Deformability / Q000187:drug effects*; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000502:physiology; D004912:Erythrocytes / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D007700:Kinetics; D008560:Membrane Fluidity / Q000187:drug effects; D010084:Oxidation-Reduction; D010545:Peroxides / Q000494:pharmacology*; D011188:Potassium / Q000097:blood; D013049:Spectrin / Q000032:analysis; D020122:tert-Butylhydroperoxide
D006454:Hemoglobins; D010545:Peroxides; D013049:Spectrin; D002245:Carbon Dioxide; D020122:tert-Butylhydroperoxide; D006861:Hydrogen Peroxide; D011188:Potassium